[go: up one dir, main page]

ATE353563T1 - Verfahren zur reinigung von hitze-schock peptidkomplexen - Google Patents

Verfahren zur reinigung von hitze-schock peptidkomplexen

Info

Publication number
ATE353563T1
ATE353563T1 AT98961905T AT98961905T ATE353563T1 AT E353563 T1 ATE353563 T1 AT E353563T1 AT 98961905 T AT98961905 T AT 98961905T AT 98961905 T AT98961905 T AT 98961905T AT E353563 T1 ATE353563 T1 AT E353563T1
Authority
AT
Austria
Prior art keywords
shock protein
heat shock
present
allergic disease
provides
Prior art date
Application number
AT98961905T
Other languages
English (en)
Inventor
Erik S Wallen
Pope L Moseley
Original Assignee
Univ New Mexico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/986,234 external-priority patent/US5981706A/en
Application filed by Univ New Mexico filed Critical Univ New Mexico
Application granted granted Critical
Publication of ATE353563T1 publication Critical patent/ATE353563T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98961905T 1997-12-05 1998-12-04 Verfahren zur reinigung von hitze-schock peptidkomplexen ATE353563T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98554897A 1997-12-05 1997-12-05
US08/986,234 US5981706A (en) 1996-09-20 1997-12-05 Methods for synthesizing heat shock protein complexes

Publications (1)

Publication Number Publication Date
ATE353563T1 true ATE353563T1 (de) 2007-03-15

Family

ID=27130630

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98961905T ATE353563T1 (de) 1997-12-05 1998-12-04 Verfahren zur reinigung von hitze-schock peptidkomplexen

Country Status (6)

Country Link
EP (1) EP1035780B1 (de)
JP (1) JP2001525347A (de)
AT (1) ATE353563T1 (de)
CA (1) CA2312049A1 (de)
DE (2) DE1035780T1 (de)
WO (1) WO1999029182A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837251A (en) 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
US6017540A (en) 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
US7235649B2 (en) 2000-03-24 2007-06-26 Duke University Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
AU2001247759A1 (en) 2000-03-24 2001-10-08 Duke University Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
WO2003029419A2 (en) 2001-10-01 2003-04-10 Duke University Three dimensional structure of crystalline grp94 binding domain, and its methods of use
AU2004213855B2 (en) 2003-02-20 2010-03-04 University Of Connecticut Health Center Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
AU2004273076B2 (en) 2003-09-11 2008-02-14 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US9090673B2 (en) 2003-12-12 2015-07-28 City Of Hope Synthetic conjugate of CpG DNA and T-help/CTL peptide
AU2004304348B2 (en) 2003-12-18 2009-02-26 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7348136B2 (en) 2004-02-19 2008-03-25 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4866848B2 (ja) 2004-06-30 2012-02-01 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルス(fiv)のenvタンパク質のv3領域に由来するペプチドの使用を含むfivを検出するための方法および装置
JP4307505B2 (ja) 2004-06-30 2009-08-05 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法と装置
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP2553452B1 (de) 2010-04-02 2015-03-04 IDEXX Laboratories, Inc. Nachweis des felinen immundefizienzvirus
EP2734231A1 (de) * 2011-07-21 2014-05-28 Biotech Tools S.A. Dosierung von dnak

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN183280B (de) * 1996-09-20 1999-10-30 Univ New Mexico

Also Published As

Publication number Publication date
CA2312049A1 (en) 1999-06-17
EP1035780B1 (de) 2007-02-14
EP1035780A1 (de) 2000-09-20
WO1999029182A1 (en) 1999-06-17
DE1035780T1 (de) 2001-02-08
EP1035780A4 (de) 2001-06-20
DE69837105D1 (de) 2007-03-29
JP2001525347A (ja) 2001-12-11

Similar Documents

Publication Publication Date Title
ATE353563T1 (de) Verfahren zur reinigung von hitze-schock peptidkomplexen
Balhorn Mammalian protamines: structure and molecular interactions
ATE337403T1 (de) Verfahren und verbindungen zur verlängerung der halbwertzeiten bei der ausscheidung von biowirksamen verbindungen
KR930017919A (ko) Cd40 b-세포 항원에 대한 역-수용체 및 이에대한 리간드
ES2106742T3 (es) Procedimiento de purificacion de proteinas.
CA2290485A1 (en) Method for the production of non-immunogenic proteins
JPH04505014A (ja) 新規の蛋白質及びその製法
ES2074562T3 (es) Anticuerpo monoclonal contra proteina c.
DE69435020D1 (en) Protein-tyrosin-phosphatase ptp-s31
DE69624096D1 (de) Verfahren zur reinigung kurzer nukleinsäuren
ATE362941T1 (de) Identifikation, reinigung und verwendungen von leczymen und karbohydratliganden
DE69734096D1 (de) Rezeptor des ob-proteins und verwandte zusammensetzungen und verfahren
ATE410514T1 (de) Calciumbindende rekombinante antikörper gegen protein c
Yeoman et al. Differences in chromatin proteins of growing and non-growing tissues
ATE368110T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
DE69433243D1 (de) Verwendunf von ApoE zum Binden von TAU und MAP2c Proteinen und zur Behandlung von Alzheimer's Krankheit
Bengtsson et al. Protein components of very low density lipoproteins from hen's egg yolk
DE69212660D1 (de) Verfahren zur Reinigung eines hochglykosylierten Proteins
EP1757311A3 (de) Verfahren und Zusammensetzungen zur Verlängerung der Entsorgungshalbwertszeit von biowirksamen Verbindungen
WO2002021138A3 (de) Die m30-genfamilie und ihre verwendung
JPH03501620A (ja) 腫瘍壊死増強因子並びに製造及び使用の方法
CA2117599A1 (en) Method for modulating proopiomelanocortin synthesis in a mammal
Bergamo et al. Detection of a sperm-coating antigen in the semen of Bubalus bubalis
SE9402490D0 (sv) Vitronection binding protein
JPS58137759A (ja) 免疫学的活性複合体

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties